Effect of chronic kidney disease on the expression of thiamin and folic acid transporters

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2137-2144

  Bukhari, Farhan J ^a   Moradi, Hamid ^b   Gollapudi, Pavan ^b   Ju Kim, Hyun ^b   Vaziri, Nosratola D ^b,c   Said, Hamid M ^a,b,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anemia; cardiovascular disease; malnutrition; neuropathy; uremia

Indexed keywords

CARRIER PROTEIN; FOLATE TRANSPORTER; FOLIC ACID; LIVER PROTEIN; THIAMIN TRANSPORTER 1; THIAMIN TRANSPORTER 2; THIAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DOWN REGULATION; FOLIC ACID BLOOD LEVEL; GENE EXPRESSION; HEART; LIVER LEVEL; MITOCHONDRION; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SHAM PROCEDURE; SMALL INTESTINE; THIAMINE BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; BLOTTING, WESTERN; BRAIN; FOLIC ACID; FOLIC ACID TRANSPORTERS; HEART; INTESTINE, SMALL; KIDNEY FAILURE, CHRONIC; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; PROTON-COUPLED FOLATE TRANSPORTER; RATS; RATS, SPRAGUE-DAWLEY; REPLICATION PROTEIN C; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAMINE;

EID: 79960017540     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq675     Document Type: Article

References (50)

1. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12. (Pubitemid 36043346)
2. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97. (Pubitemid 47016250)
3. Krishnan AV, Kiernan MC. Neurological complications of chronic kidney disease. Nat Rev Neurol 2009; 5: 542-551.
4. Blakley RL, Benkovic SJ. Folates and Peterines. Chemistry and Biochemistry of Folate. 1985; Vol. 3 New York: Wiley and Sons.
5. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71: 121-138.
6. Stanger O. Physiology of folic acid in health and disease. Curr Drug Metab 2002; 3: 211-223. (Pubitemid 34326532)
7. Hazell AS, Butterworth RF. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. Alcohol Alcohol 2009; 44: 141-147.
8. Gioda CR, de Oliveira Barreto T, Primola-Gomes TN et al. Cardiac oxidative stress is involved in heart failure induced by thiamine deprivation in rats. Am J Physiol Heart Circ Physiol 2010; 298: H2039-H2045.
9. Calingasan NY, Chun WJ, Park LC et al. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency. J Neuropathol Exp Neurol 1999; 58: 946-958. (Pubitemid 29441923)
10. Langlais PJ, Anderson G, Guo SX et al. Increased cerebral free radical production during thiamine deficiency. Metab Brain Dis 1997; 12: 137-143. (Pubitemid 27264265)
11. Boros LG, Lee PW, Brandes JL et al. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? Med Hypotheses 1998; 50: 55-59. (Pubitemid 28046401)
12. Nguyen TT, Dyer DL, Dunning DD et al. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology 1997; 1112: 783-791. (Pubitemid 27113804)
13. Said HM, Mohammed ZM. Intestinal absorption of water-soluble vitamins: an update. Curr Opin Gastroenterol 2006; 22: 140-146. (Pubitemid 44090079)
14. Qiu A, Min SH, Jansen M et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006; 127: 917-928. (Pubitemid 44792250)
15. Reidling JC, Nabokina SM, Balamurugan K et al. Developmental maturation of intestinal and renal thiamin uptake: studies in wild-type and transgenic mice carrying human THTR-1 and 2 promoters. J Cell Physiol 2006; 206: 371-377. (Pubitemid 43062805)
16. SaidHM, BalamuruganK, Subramanian VS et al. Expression and functional contribution of hTHTR-2 in thiamin absorption in human intestine. Am J Physiol Gastrointest Liver Physiol 2004; 286: G491-G498. (Pubitemid 38250322)
17. Reidling JC, Said HM. In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2. Am J Physiol Cell Physiol 2003; 285: C633-C641. (Pubitemid 37022062)
18. Reidling JC, Said HM. Adaptive regulation of intestinal thiamin uptake: molecular mechanism using wild-type and transgenic mice carrying hTHTR-1 and -2 promoters. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1127-G1134. (Pubitemid 40741064)
19. Descombes E, Boulat O, Perriard F et al. Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving longterm oral postdialysis vitamin supplementation. Artif Organs 2000; 24: 773-778.
20. Niwa T, Ito T, Matsui E et al. Plasma level and transfer capacity of thiamin in patients undergoing long-term hemodialysis. Am J Clin Nutr 1975; 28: 1105-1109.
21. Hung SC, Hung SH, Tarng DC et al. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2001; 38: 941-947.
22. Levin A, Singer J, Thompson CR et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-354. (Pubitemid 26075843)
23. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473. (Pubitemid 39361056)
24. Said HM, Vaziri ND, Kariger RK et al. Intestinal absorption of 5-methyltetrahydrofolate in experimental uremia. Acta Vitaminol Enzymol 1984; 6: 339-346. (Pubitemid 15138910)
25. Said HM, Vaziri ND, Oveisi F et al. Effect of chronic renal failure on intestinal transport of biotin in the rat. J Lab Clin Med 1992; 120: 471-475.
26. Vaziri ND, Said HM, Hollander D et al. Impaired intestinal absorption of riboflavin in experimental uremia. Nephron 1985; 41: 26-29. (Pubitemid 15006028)
27. Barbari A, Vaziri ND, Benavides I et al. Intestinal transport of pyridoxine in experimental renal failure. Life Sci 1989; 45: 663-669. (Pubitemid 19198553)
28. Naud J, Michaud J, Leblond FA et al. Effects of chronic renal failure on liver drug transporters. Drug Metab Dispos 2008; 36: 124-128.
29. Naud J, Michaud J, Boisvert C et al. Down-regulation of intestinal drug transporters in chronic renal failure in rats. J Pharmacol Exp Ther 2007; 320: 978-985. (Pubitemid 46294060)
30. Deguchi T, Isozaki K, Yousuke K et al. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neurochem 2006; 96: 1051-1059.
31. Chang CM, Yu CC, Lu HT et al. Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver. Br J Nutr 2007; 97: 855-863.
32. Chou YF, Yu CC, Huang RF. Changes in mitochondrial DNA deletion, content, and biogenesis in folate-deficient tissues of young rats depend on mitochondrial folate and oxidative DNA injuries. J Nutr 2007; 137: 2036-2042.
33. Yeo EJ,Wagner C. Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver. Proc Natl Acad Sci USA 1994; 91: 210-214.
34. Chanson A, Sayd T, Rock E et al. Proteomic analysis reveals changes in the liver protein pattern of rats exposed to dietary folate deficiency. J Nutr 2005; 135: 2524-2529. (Pubitemid 43156590)
35. Scott JM, Weir DG. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J Cardiovasc Risk 1998; 5: 223-227. (Pubitemid 29030107)
36. Kronenberg G, Colla M, Endres M. Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med 2009; 9: 315-323.
37. Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms. Biofactors 2009; 35: 120-129.
38. Lawrence de Koning AB, Werstuck GH, Zhou J et al. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin Biochem 2003; 36: 431-441. (Pubitemid 37086702)
39. Ferechide D, Radulescu D. Hyperhomocysteinemia in renal diseases. J Med Life 2009; 2: 53-59.
40. Nerbass FB, Draibe SA, Feiten SF et al. Homocysteine and its determinants in nondialyzed chronic kidney disease patients. J Am Diet Assoc 2006; 106: 267-270. (Pubitemid 43151250)
41. Jamison RL, Hartigan P, Kaufman JS et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007; 298: 1163-1170. (Pubitemid 47403102)
42. Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin 2010; 28: 107-170.
43. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev 2005; 1: 287-298.
44. Soukoulis V, Dihu JB, Sole M et al. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol 2009; 54: 1660-1673.
45. Suzuki M, Tsutsui M, Yokoyama A et al. Normalization of hematocrit with recombinant human erythropoietin in chronic hemodialysis patients does not fully improve their exercise tolerance abilities. Artif Organs 1995; 19: 1258-1261. (Pubitemid 26167347)
46. Nozaki S, Mizuma H, Tanaka M et al. Thiamine tetrahydrofurfuryl disulfide improves energy metabolism and physical performance during physical-fatigue loading in rats. Nutr Res 2009; 29: 867-872.
47. Gibson GE, Blass JP. Thiamine-dependent processes and treatment strategies in neurodegeneration. Antioxid Redox Signal 2007; 9: 1605-1619. (Pubitemid 47462965)
48. Alexander-Kaufman K, Harper C. Transketolase: observations in alcohol-related brain damage research. Int J Biochem Cell Biol 2009; 41: 717-720.
49. Sterzel RB, Semar M, Lonergan ET et al. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia. J Clin Invest 1971; 50: 2295-2304.
50. Spiegel R, Shaag A, Edvardson S et al. SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. Ann Neurol 2009; 66: 419-424